Table 2.

Patient demographics: comparison between intervention and control groups

Variable	Intervention (N = 34)	Control (N = 41)	Total (N = 75)	p value
Age, years, mean (SD)	58.68 (9.77)	55.15 (14.90)	56.75 (12.87)	0.240
Gender, n (%)				0.066
Female	17 (50.00%)	29 (70.73%)	46 (61.33%)
Male	17 (50.00%)	12 (29.27%)	29 (38.67%)
Race, n (%)				0.232
White/Caucasian	26 (76.47%)	36 (87.80%)	62 (82.67%)
Black/African American	7 (20.59%)	3 (7.32%)	10 (13.33%)
Other	1 (2.94%)	2 (4.88%)	3 (4.00%)
Education, years, n (%)				0.011
High school	10 (29.41%)	2 (4.88%)	12 (16.00%)
GED or vocational school	1 (2.94%)	2 (4.88%)	3 (4.00%)
13 years—bachelor’s degree	20 (58.82%)	25 (60.98%)	45 (60.00%)
Higher degree	3 (8.82%)	12 (29.27%)	15 (20.00%)
Height, cm, mean (SD)	170.74 (11.50)	168.58 (7.99)	169.56 (9.73)	0.341
Weight at most recent clinic visit, kg, mean (SD)	85.64 (19.51)	89.55 (26.65)	87.78 (23.61)	0.479
BMI mean (SD)	29.33 (5.97)	31.58 (9.74)	30.56 (8.27)	0.243
Heart rate (HR), beats/min, mean (SD)	70.99 (17.32)	73.74 (13.78)	72.67 (15.17)	0.492
Diastolic blood pressure, mmHg, mean (SD)	77.12 (9.69)	75.20 (8.08)	76.07 (8.84)	0.352
Charlson comorbidity index, mean (SD)	0.62 (1.16)	0.59 (0.89)	0.60 (1.01)	0.892
Katz scale score, mean (SD)	6.00 (0.00)	6.00 (0.00)	6.00 (0.00)	0.275
Lawton scale score, mean (SD)	8.00 (0.00)	8.00 (0.00)	8.00 (0.00)	0.275
Insurance, n (%)				0.269
Yes	33 (97.06%)	41 (100.00%)	74 (98.67%)
No	1 (2.94%)	0 (0.00%)	1 (1.33%)
Prior experience with a sleep tracker, n (%)				0.788
Yes	25 (73.53%)	29 (70.73%)	54 (72.00%)
No	9 (26.47%)	12 (29.27%)	21 (28.00%)
Medications at baseline n (%)				0.182
Antidiabetic	2 (5.88%)	1 (2.44%)	3 (4.00%)
Antihypertensive	5 (14.71%)	1 (2.44%)	6 (8.00%)
Sedating	15 (44.12%)	19 (46.34%)	34 (45.33%)
Other	12 (35.29%)	20 (48.78%)	32 (42.67%)